Skin Cancer

Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Colt DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JK, McMasters KM, Mihn MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF. Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19 (16): 3635-3648.

Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 2000; 36: 387-402.

Blessing K. Benign atypical naevi: diagnostic difficulties and continued controversy. Histopathology 1999; 34: 189-198.

Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-908.

Cerroni L, Kerl H, Gatter K. An illustrated guide to skin lymphoma. Blackwell Scientific. Oxford 1998.

Clark WH Jr. A classification of malignant melanoma in man correlated with histogenesis and biological behaviour. In: Montagna W, Hu F (eds).Advances in Biology of the Skin. Vol. 8. Pergamon Press. London 1967; 621-627.

Cochran AJ, Bailly C, Cook M, Crotty K, Mihm M, Mooi W, Sagebiel R. Recommendations for the reporting of tissues removed as part of the surgical treatment of cutaneous melanoma. Hum Pathol 1997; 28: 1123-1125.

Cook MG. Problems in the histological assessment of melanoma emphasising the importance of the vertical/nodular component. Curr Diagn Pathol 1994; 1: 98-104.

Cook MG. A practical approach to spindle cell melanocytic lesions. CPD Bulletin Cellular Pathology 1999; 1(3): 101-104.

Cook MG, Clarke TJ, Humphreys S, Fletcher A, McLaren KM, Smith NP, Stevens A, Theaker JM, Melia J. The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathology 1996; 28: 497-512.

Cook MG. Sentinel lymph node biopsy for melanoma. Curr Diagn Pathol 2003; 9: 296-301.

Cook MG. Diagnostic pitfalls with melanocytic tumours. Curr Diagn Pathol 2004; 10: 463-472.

Culpepper KS, Granter SR, McKee PH. My approach to atypical melanocytic lesions. J Clin Pathol 2004; 57: 1121-1131.

DeWit NJW, Van Muijen GNP, Ruiter DJ. Immunohistochemistry in melanocytic proliferative lesions. Histopathology 2004; 44: 517-541.

Edwards SL, Blessing K. Problematic pigmented lesions: approach to diagnosis. J Clin Pathol 2000; 53: 409-418.

Elder DE, Murphy GF. Melanocytic tumors of the skin. Atlas of tumor pathology. 3rd series. Fascicle 2. AFIP. Washington 1991.

Elder DE, Johnson B, Elenitsas R. Lever's Histopathology of the Skin, 9th edn. Lippincott, Williams and Wilkins. Philadelphia 2004.

Goodland JR, Hollowood K. Primary cutaneous B-cell lymphoma. Curr Diagn Pathol 2001; 7: 33-40.

Hollowood K. The diagnosis of sweat gland carcinomas: a practical approach. CPD Bulletin Cellular Pathology 1999; 1(3): 105-110.

Kirkham N. Malignant melanoma: progress in diagnosis and prognosis. In: Kirkham N, Lemoine NR (eds). Progress in pathology 4. Churchill Livingstone. Edinburgh 1998; 241-253.

Kirkham N. Optimal handling and criteria for melanoma diagnosis. Histopathology 2000; 37: 464-472.

Kirkham N. The differential diagnosis of thin malignant melanoma. Curr Diagn Pathol 2003; 9: 281-286.

McKee PH, Calonje E, Granter SR. Pathology of the skin with clinical correlations, 3rd edn. Mosby. London 2005.

Mooi WJ. The dysplastic naevus. J Clin Pathol 1997; 50: 711-715.

Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002; 146(1): 18-25.

Murphy GF, Elder DE. Non-melanocytic tumors of the skin. Atlas of tumor pathology. 3rd series. Fascicle 1. AFIP. Washington 1991.

Rippey JJ. Why classify basal cell carcinomas? Histopathology 1998; 32: 393-398.

Sakkinen P, Kohler S. Histologic mimickers of thick melanoma. Curr Diagn Pathol 2003; 9: 287-295.

Sanders DSA, Blessing K. Guidelines on reporting cutaneous malignant melanoma. CPD Bulletin Cellular Pathology 1999; 1(3): 97-100.

Slater DN. Classification and diagnosis of cutaneous lymphoproliferative disorders. In: Lowe DG, Underwood SCE (eds). Recent Advances in Histopathology 20. RSM Press. London 2003; 53-72.

Spatz A, Shaw HM, Crotty KA, Thompson JF, McCarthy SW. Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (>5mm). Histopathology 1998; 33: 406-413.

Weedon D, LeBoit P, Burg G, Sarasin A (eds). World Health Organisation Classification of Tumours. Pathology and Genetics. Tumours of the Skin. IARC Press. Lyon 2005.

Weedon D. Skin Pathology, 2nd edn. Churchill Livingstone. London 2002.

Willemze R, Meijer CJLM. Classification of cutaneous lymphomas: crosstalk between pathologist and clinician. Curr Diagn Pathol 1998; 5: 23-33.

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment